Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (101-110 of 522) with videos related to

Pageof 53
Sort By:
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
European Urology|May 14, 2017
Community-based Outcomes of Open versus Robot-assisted Radical ProstatectomyAnnika Herlemann, Janet E Cowan, Peter R Carroll, et al.
Translational Andrology and Urology|July 28, 2018
Genomic biomarkers in prostate cancerZachary Kornberg, Matthew R Cooperberg, Daniel E Spratt, et al.
Cancer|January 7, 2011
Inaccuracies in assignment of clinical stage for localized prostate cancerAdam C Reese, Natalia Sadetsky, Peter R Carroll, et al.
The Journal of Urology|June 18, 2011
Treatment trends for stage I renal cell carcinomaMatthew R Cooperberg, Katherine Mallin, Christopher J Kane, et al.
The Journal of Urology|October 22, 2008
Health related quality of life in patients treated with multimodal therapy for prostate cancerAlex K Wu, Matthew R Cooperberg, Natalia Sadetsky, et al.
Annals of Internal Medicine|September 16, 2014
A simple schema for informed decision making about prostate cancer screeningAndrew J Vickers, Kelly Edwards, Matthew R Cooperberg, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Fertility and Sterility|September 20, 2005
Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injectionMatthew R Cooperberg, Thomas Chi, Amir Jad, et al.
BJU International|September 20, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancerMatthew R Cooperberg, Shiro Hinotsu, Mikio Namiki, et al.
Pageof 53

Showing results (101-110 of 522) with videos related to

Sort By:
Pageof 53
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
European Urology|May 14, 2017
Community-based Outcomes of Open versus Robot-assisted Radical ProstatectomyAnnika Herlemann, Janet E Cowan, Peter R Carroll, et al.
Translational Andrology and Urology|July 28, 2018
Genomic biomarkers in prostate cancerZachary Kornberg, Matthew R Cooperberg, Daniel E Spratt, et al.
Cancer|January 7, 2011
Inaccuracies in assignment of clinical stage for localized prostate cancerAdam C Reese, Natalia Sadetsky, Peter R Carroll, et al.
The Journal of Urology|June 18, 2011
Treatment trends for stage I renal cell carcinomaMatthew R Cooperberg, Katherine Mallin, Christopher J Kane, et al.
The Journal of Urology|October 22, 2008
Health related quality of life in patients treated with multimodal therapy for prostate cancerAlex K Wu, Matthew R Cooperberg, Natalia Sadetsky, et al.
Annals of Internal Medicine|September 16, 2014
A simple schema for informed decision making about prostate cancer screeningAndrew J Vickers, Kelly Edwards, Matthew R Cooperberg, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Fertility and Sterility|September 20, 2005
Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injectionMatthew R Cooperberg, Thomas Chi, Amir Jad, et al.
BJU International|September 20, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancerMatthew R Cooperberg, Shiro Hinotsu, Mikio Namiki, et al.
Pageof 53